register

News & Trends - MedTech & Diagnostics

How Medtronic is strengthening its robotics portfolio

Health Industry Hub | March 13, 2023 |

MedTech News: The use of robotic-assisted surgery in gynaecology has expanded in recent years owing to technical advances.

Hurstville Private Hospital is the first in Australia to offer patients access to minimally invasive procedures with Medtronic’s Hugo Robotic Assisted Surgery (RAS) system.

The surgeon who performed the first procedures was Gynaecologist, Dr Danny Chou.

“Hugo RAS is the latest surgical robotic platform with enhanced capability that facilitates surgical procedures and it’s a very exciting advancement in the field of minimal invasive gynaecological surgery,” stated Dr Chou.

Last week Dr Chou demonstrated the robot by livestream for colleagues attending the Sydney Women’s Endosurgery Centre and Australian Gynaecological Endoscopy Surgery Meeting, showcasing the robot’s capability. 

A meta-analysis by Shazly et al assessed robotic-assisted laparoscopy for radical hysterectomy in cervical cancer and concluded that there were fewer complications for robotic-assisted surgery compared with open surgery.

In the study of 5654 patients by Jorgensen et al, improved survival and reduced risk of severe complications were seen in women with early-stage endometrial cancer who underwent robotic-assisted laparoscopy vs conventional surgery.

In the case of Medtronic’s Hugo, the system has a modular design, with each of the robotic arms mounted on a separate cart so that the surgeon need not use all of them for more straightforward procedures. It also has powerful data and analytics capabilities including Touch Surgery Enterprise to record, store and analyse surgical videos.

“This is an incredibly exciting moment for Hurstville Private Hospital as we continue to expand our portfolio of offerings in robotic-assisted surgery. The Hugo RAS system is an investment in our patients and underscores our commitment to provide them with the latest advancements in medical technology and the best possible care,” said Martina Goddard, Deputy Chief Executive Officer, Hurstville Private Hospital

One of the perceived limitations of robotic surgery remains its higher costs. A meta-analysis of 36 studies by Ind et al. reported that robotic-assisted laparoscopy hysterectomy is associated with favourable clinical outcomes, with shorter stays in hospital, reduced blood loss, conversions to laparotomy and lower overall complications, but it is more expensive than conventional laparoscopy in gynaecological surgery. However, studies looking at long term cost-effectiveness of robotics in gynaecological surgery need to consider the complexity of the surgical procedure and women’s comorbidities.

Hurstville Private Hospital in Sydney’s south has been recognised as a Centre of Excellence in Robotic Surgery, Colorectal Surgery and Minimally Invasive Surgery by the Surgical Review Corporation, the first hospital in Sydney to be recognised with the prestigious accreditation.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms

Health Industry Hub | April 17, 2025 |

Hospitals shouldn’t be forced to grovel to private health insurers to secure funding for essential, lifesaving medical devices. But thanks […]

More


News & Trends - Pharmaceuticals

Oncologists pioneer liquid biopsy-guided treatment in lung cancer

Oncologists pioneer liquid biopsy-guided treatment in lung cancer

Health Industry Hub | April 17, 2025 |

Lung cancer is Australia’s leading cause of cancer deaths. Local experts are set to lead a new frontier in personalised […]

More


Medical and Science

The high cost of record low research funding

The high cost of record low research funding

Health Industry Hub | April 17, 2025 |

Australia has delivered some of the world’s most transformative health and medical breakthroughs – the cochlear implant, the HPV vaccine, […]

More


News & Trends - Pharmaceuticals

UCB secures dermatology indication with first dual IL-17A/F inhibitor

UCB secures dermatology indication with first dual IL-17A/F inhibitor

Health Industry Hub | April 17, 2025 |

UCB’s IL-17A and IL-17F inhibitor has been added to the Australian Register of Therapeutic Goods (ARTG) for adults with moderate […]

More


This content is copyright protected. Please subscribe to gain access.